United States · FDA National Drug Code directory
Terazosin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-4064_d1718217-ddab-4a3a-a862-8c952fd5a274
- Product NDC
- 68788-4064
- Form
- CAPSULE
- Composition / generic term
- Terazosin
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260128
- Source listing expiry
- 20271231
Source-listed ingredients
- TERAZOSIN HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68788-4064-1) · 68788-4064-1
- 30 CAPSULE in 1 BOTTLE (68788-4064-3) · 68788-4064-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →